Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
66 hedge funds and large institutions have $449M invested in Taro Pharmaceutical Industries Ltd. in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 7 closing their positions.
171% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 7
29% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 17
20% more funds holding
Funds holding: 55 → 66 (+11)
10% more capital invested
Capital invested by funds: $408M → $449M (+$41M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
+$7.56M |
| 2 |
Morgan Stanley
New York
|
+$6.11M |
| 3 |
PA
Perceptive Advisors
New York
|
+$4.4M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.26M |
| 5 |
Renaissance Technologies
New York
|
+$3.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Assured Investment Management
New York
|
-$21.6M |
| 2 |
GCM
Greywolf Capital Management
Purchase,
New York
|
-$20.7M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$8.13M |
| 4 |
PCM
PAR Capital Management
Boston,
Massachusetts
|
-$3.8M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.46M |
TARO Hedge Fund Activity: Q1 2014 in Review
66 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q1 2014, worth a combined $449M — up 10% from $408M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new TARO positions and 7 closed out — a net gain of 12 holders — while 22 added to existing stakes and 17 trimmed.
The largest buyer was Raging Capital Management, adding an estimated $7.56M. The largest seller was Assured Investment Management, cutting an estimated $21.6M.
- 66 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q1 2014, up from 55 in Q4 2013.
- Funds reported $449M of Taro Pharmaceutical Industries Ltd. stock for Q1 2014, up 10% quarter-over-quarter.
- 19 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q1 2014 and 7 closed out, a net change of +12 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q1 2014 was Raging Capital Management, an estimated $7.56M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q1 2014 was Assured Investment Management, an estimated $21.6M sold.
Based on aggregated 13F filings for Q1 2014.